Sinopharm’s COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study

December 31, 2020 Auto Bot Clinical Trials, reports, results 0

Shots:

  • The results of an interim analysis of P-III study showed that the safety of the new coronavirus inactivated vaccine after inoculation
  • All patients produced high-titer Abs, the neutralizing Ab positive conversion rate was 99.52% while vaccine efficacy was 79.34%
  • The vaccine has been granted authorization in several countries and has also been rolled out in part in China. The company is now seeking full approval in China

Click here ­to­ read full press release/ article | Ref: Sinopharm | Image: Sinopharm

The post Sinopharm’s COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study first appeared on PharmaShots.